CE vs CRL · rev $5.09B vs rev $2.00B
Celanese Corporation (CE) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported CE revenue for 2026-06-30 was $5.09B. Net income was $169.0M. CE currently screens at market cap $5.92B.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
CE currently screens at market cap $5.92B. CRL currently screens at market cap $7.78B.
Not investment advice. Open the CE and CRL stock pages for the full models.
Not investment advice.